
  
    
      
        Synopsis_NNP
        
          Introduction_NNP
          In_IN RA_NNP large_JJ numbers_NNS of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS infiltrate_VB
          the_DT inflamed_JJ synovium_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._. The_DT accumulated_VBN CD_NNP 4_CD
          +_NN memory_NN T_NN cells_NNS in_IN the_DT RA_NNP synovium_NN appear_VBP to_TO be_VB
          activated_VBN ,_, because_IN they_PRP express_VBP cytokines_NNS and_CC activation_NN
          markers_NNS [_NN 4_CD ,_, 5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ]_NN ._. Expressed_NNP cytokines_NNS and_CC
          activation_NN markers_NNS should_MD play_VB important_JJ roles_NNS in_IN the_DT
          pathogenesis_NNS of_IN RA_NNP ._. However_RB ,_, the_DT frequency_NN of_IN cytokine_NN
          expression_NN by_IN RA_NNP synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS has_VBZ not_RB been_VBN
          analyzed_VBN accurately_RB ._. Recently_RB ,_, the_DT roles_NNS of_IN chemokine_NN and_CC
          chemokine_NN receptor_NN interactions_NNS in_IN T-_NNP cell_NN migration_NN have_VBP
          been_VBN intensively_RB examined_VBN ._. Interactions_NNP of_IN chemokine_NN and_CC
          chemokine_NN receptors_NNS might_MD therefore_RB be_VB important_JJ in_IN the_DT
          accumulation_NN of_IN the_DT CD_NNP 4_CD +_NN T_NN cells_NNS in_IN the_DT RA_NNP synovium_NN ._.
          Accordingly_RB ,_, correlation_NN of_IN cytokine_NN and_CC chemokine_NN
          receptor_NN expression_NN might_MD be_VB important_JJ in_IN delineating_VBG the_DT
          function_NN and_CC potential_JJ means_NNS of_IN accumulation_NN of_IN
          individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS in_IN the_DT RA_NNP synovium_NN ._.
          In_IN the_DT present_JJ study_NN we_PRP analyzed_VBD cytokine_NN (_( IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_,
          IL-_NNP 6_CD ,_, IL-_NNP 10_CD ,_, IL-_NNP 13_CD ,_, IFN-γ_NNP ,_, TNF-α_NNP ,_, and_CC LT-α_NNP )_) ,_,
          activation_NN marker_NN (_( CD_NNP 154_CD [_NN CD_NNP 40_CD ligand_NN ]_NN and_CC TRANCE_NNP -_: also_RB
          called_VBN receptor_NN activator_NN of_IN nuclear_JJ factor_NN κ_NN B_NNP ligand_NN
          [_NN RANKL_NNP ]_NN or_CC osteoclast_NN differentiation_NN factor_NN [_NN ODF_NNP ]_NN )_) ,_, and_CC
          chemokine_NN receptor_NN expression_NN by_IN individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN
          cells_NNS isolated_VBN from_IN rheumatoid_NN synovium_NN and_CC blood_NN ._. To_TO
          achieve_VB this_DT we_PRP employed_VBN a_DT single-cell_JJ reverse_NN
          transcription_NN (_( RT_NNP )_) polymerase_NN chain_NN reaction_NN (_( PCR_NNP )_)
          technique_NN ._. This_DT technique_NN made_VBD it_PRP possible_JJ to_TO correlate_VBP
          mRNAs_NNS expressed_VBN by_IN individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS in_IN the_DT
          synovium_NN and_CC blood_NN ._.
        
        
          Materials_NNS and_CC method_NN
          Synovial_NNP tissues_NNS from_IN three_CD RA_NNP patients_NNS and_CC peripheral_JJ
          blood_NN mononuclear_NN cells_NNS from_IN two_CD RA_NNP patients_NNS and_CC a_DT normal_JJ
          donor_NN were_VBD analyzed_VBN ._.
          Cytokine_NNP (_( IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, IL-_NNP 6_CD ,_, IL-_NNP 10_CD ,_, IL-_NNP 13_CD ,_, IFN-γ_NNP ,_,
          TNF-α_NNP ,_, and_CC LT-α_NNP )_) and_CC activation_NN marker_NN (_( CD_NNP 154_CD and_CC
          TRANCE_NNP )_) expression_NN by_IN individual_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS
          from_IN RA_NNP synovium_NN or_CC blood_NN were_VBD analyzed_VBN using_VBG a_DT
          single-cell_JJ RT-PCR_NNP ._. In_IN brief_JJ ,_, single_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS
          was_VBD sorted_VBN into_IN each_DT well_RB of_IN a_DT 96_CD -_: well_RB PCR_NNP plate_NN using_VBG a_DT
          flow_NN cytometer_NN ._. cDNA_NN from_IN individual_JJ cells_NNS was_VBD prepared_VBN ,_,
          and_CC then_RB the_DT cDNA_NN was_VBD nonspecifically_RB amplified_VBN ._. The_DT
          product_NN was_VBD then_RB amplified_VBN by_IN PCR_NNP using_VBG gene-specific_JJ
          primers_NNS to_TO analyze_VB cytokine_NN and_CC activation_NN marker_NN
          expression_NN ._.
        
        
          Results_NNS
          Cytokine_NNP and_CC activation_NN marker_NN expression_NN by_IN
          individual_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS from_IN RA_NNP synovial_NN tissues_NNS
          was_VBD analyzed_VBN using_VBG a_DT single-cell_JJ RT-PCR_NNP method_NN ._.
          Expression_NNP of_IN mRNAs_NNS was_VBD analyzed_VBN in_IN 152_CD individual_JJ
          synovial_NN tissue_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS sorted_VBN from_IN three_CD RA_NNP
          patients_NNS in_IN which_WDT T-_NNP cell_NN receptor_NN (_( TCR_NNP )_) Cβ_NNP mRNA_NN was_VBD
          detected_VBN ._. Frequencies_NNP of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS expressing_VBG
          cytokine_NN and_CC activation_NN marker_NN mRNA_NN in_IN RA_NNP synovium_NN are_VBP
          shown_VBN in_IN Table_NNP 1_CD ._. IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, and_CC IL-_NNP 6_CD were_VBD not_RB expressed_VBN
          by_IN the_DT synovial_NN tissue_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS ,_, whereas_IN
          2_CD -_: 20_CD %_NN of_IN cells_NNS expressed_VBD the_DT other_JJ cytokine_NN mRNAs_NNS ._.
          Few_JJ correlations_NNS between_IN cytokine_NN and_CC activation_NN
          marker_NN mRNAs_NNS were_VBD observed_VBN ._. Notably_RB ,_, no_DT cells_NNS contained_VBD
          both_DT IFN-γ_NNP and_CC LT-α_NNP mRNAs_NNS ,_, cytokines_NNS that_WDT are_VBP thought_VBN to_TO
          define_VB the_DT T-_NNP helper_NN (_( Th_NNP )_) 1_CD phenotype_NN [_NN 9_CD ]_NN ._. However_RB ,_, the_DT
          frequency_NN of_IN TRANCE-positive_NNP cells_NNS in_IN IL-_NNP 10_CD -_: positive_JJ
          cells_NNS was_VBD significantly_RB higher_JJR than_IN that_DT in_IN
          IL-_NNP 10_CD -_: negative_JJ cells_NNS (_( Table_NNP 2_LS )_) ._. Moreover_RB ,_, the_DT frequency_NN
          of_IN TRANCE-positive_NNP cells_NNS in_IN TNF-α-positive_NNP cells_NNS was_VBD also_RB
          significantly_RB higher_JJR than_IN that_DT in_IN TNF-α-negative_NNP
          cells_NNS ._.
          Varying_JJ percentages_NNS of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS expressed_VBD
          CC_NNP and_CC CXC_NNP chemokine_NN receptors_NNS ._. The_DT frequency_NN of_IN
          CCR_NNP 5_CD -_: positive_JJ cells_NNS in_IN IFN-γ-positive_NNP cells_NNS was_VBD
          significantly_RB higher_JJR than_IN that_DT in_IN IFN-γ-negative_NNP cells_NNS ,_,
          whereas_IN the_DT frequency_NN of_IN CCR_NNP 6_CD -_: positive_JJ cells_NNS in_IN
          LT-α-positive_NNP cells_NNS was_VBD significantly_RB higher_JJR than_IN that_DT in_IN
          LT-α-negative_NNP cells_NNS ,_, and_CC the_DT frequency_NN of_IN CCR_NNP 7_CD -_: positive_JJ
          cells_NNS in_IN IL-_NNP 10_CD -_: positive_JJ cells_NNS was_VBD significantly_RB higher_JJR
          than_IN that_DT in_IN IL-_NNP 10_CD -_: negative_JJ cells_NNS ._. Furthermore_RB ,_, the_DT
          frequency_NN of_IN CXCR_NNP 4_CD -_: positive_JJ cells_NNS in_IN TRANCE-positive_NNP
          cells_NNS was_VBD significantly_RB higher_JJR than_IN that_DT in_IN
          TRANCE-negative_NNP cells_NNS ._.
          Expression_NNP of_IN cytokine_NN and_CC activation_NN marker_NN mRNAs_NNS was_VBD
          also_RB analyzed_VBN in_IN 48_CD individual_JJ peripheral_JJ blood_NN CD_NNP 4_CD
          +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS from_IN two_CD RA_NNP patients_NNS ._. IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, IL-_NNP 6_CD ,_,
          and_CC LT-α_NNP were_VBD not_RB expressed_VBN by_IN the_DT peripheral_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP
          +_NN T_NN cells_NNS ,_, whereas_IN 4_CD -_: 17_CD %_NN of_IN cells_NNS expressed_VBD the_DT other_JJ
          markers_NNS ._. The_DT most_RBS striking_JJ difference_NN between_IN synovial_NN
          tissue_NN and_CC peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS was_VBD the_DT
          presence_NN of_IN LT-α_NNP expression_NN in_IN the_DT former_NN ,_, but_CC not_RB in_IN the_DT
          latter_NN ._. IFN-γ_NNP and_CC TNF-α_NNP were_VBD not_RB expressed_VBN by_IN normal_JJ
          peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ,_, although_IN they_PRP were_VBD
          expressed_VBN by_IN RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._.
        
        
          Discussion_NNP
          The_DT present_JJ study_NN employed_VBN a_DT single-cell_JJ PCR_NNP
          technology_NN to_TO analyze_VB cytokine_NN expression_NN by_IN unstimulated_JJ
          RA_NNP synovial_NN tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS immediately_RB after_IN
          isolation_NN ,_, without_IN 
          in_IN vitro_NN manipulation_NN ._. The_DT results_NNS
          confirm_VBP the_DT Th_NNP 1_CD nature_NN of_IN rheumatoid_NN inflammation_NN ._. It_PRP is_VBZ
          noteworthy_JJ that_IN no_DT individual_JJ synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN
          cells_NNS expressed_VBD both_DT IFN-γ_NNP and_CC LT-α_NNP mRNAs_NNS ,_, even_RB though_IN
          these_DT are_VBP the_DT prototypic_JJ Th_NNP 1_CD cytokines_NNS [_NN 9_CD ]_NN ._. These_DT
          results_NNS imply_VBP that_IN ,_, in_IN the_DT synovium_NN ,_, regulation_NN of_IN IFN-γ_NNP
          and_CC LT-α_NNP must_MD vary_VB in_IN individual_JJ cells_NNS ,_, even_RB though_IN both_DT
          Th_NNP 1_CD cytokines_NNS can_MD be_VB produced_VBN ._.
          The_DT present_JJ data_NN showed_VBD that_IN CCR_NNP 5_CD expression_NN
          correlated_JJ with_IN IFN-γ_NNP but_CC not_RB with_IN LT-α_NNP expression_NN by_IN
          synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. It_PRP has_VBZ been_VBN reported_VBN that_IN
          CCR_NNP 5_CD expression_NN is_VBZ upregulated_JJ in_IN RA_NNP synovial_NN fluid_NN and_CC
          synovial_NN tissue_NN T_NN cells_NNS [_NN 10_CD ,_, 11_CD ,_, 12_CD ]_NN and_CC that_IN CCR_NNP 5_CD Δ_NN 32_CD
          deletion_NN may_MD have_VB an_DT influence_NN on_IN clinical_JJ manifestations_NNS
          of_IN RA_NNP [_NN 13_CD ]_NN ,_, suggesting_VBG that_IN CCR_NNP 5_CD might_MD play_VB an_DT important_JJ
          role_NN in_IN RA_NNP ._. Recently_RB ,_, it_PRP has_VBZ been_VBN claimed_VBN that_IN CCR_NNP 5_CD was_VBD
          preferentially_RB expressed_VBN by_IN Th_NNP 1_CD cell_NN lines_NNS [_NN 14_CD ,_, 15_CD ]_NN ._.
          However_RB ,_, in_IN the_DT present_JJ study_NN CCR_NNP 5_CD was_VBD not_RB expressed_VBN by_IN
          all_DT IFN-γ-expressing_NNP cells_NNS ._. Moreover_RB ,_, CCR_NNP 5_CD expression_NN did_VBD
          not_RB correlate_VBP with_IN expression_NN of_IN LT-α_NNP by_IN RA_NNP synovial_NN CD_NNP 4_CD
          +_NN memory_NN T_NN cells_NNS ._. Therefore_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN CCR_NNP 5_CD is_VBZ
          a_DT marker_NN of_IN Th_NNP 1_CD cells_NNS in_IN RA_NNP synovium_NN ._.
          IL-_NNP 10_CD expression_NN correlated_JJ with_IN CCR_NNP 7_CD expression_NN by_IN RA_NNP
          synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. Recently_RB ,_, it_PRP was_VBD reported_VBN [_NN
          16_CD ]_NN that_IN in_IN the_DT blood_NN CCR_NNP 7_CD +_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS express_VBP
          lymph-node_JJ homing_VBG receptors_NNS and_CC lack_NN immediate_JJ effector_NN
          function_NN ,_, but_CC efficiently_RB stimulate_VB dendritic_JJ cells_NNS ._.
          These_DT cells_NNS may_MD play_VB a_DT unique_JJ role_NN in_IN the_DT synovium_NN as_IN
          opposed_VBN to_TO in_IN the_DT blood_NN ._. By_IN producing_VBG IL-_NNP 10_CD ,_, they_PRP might_MD
          have_VB an_DT immunoregulatory_NN function_NN ._. In_IN addition_NN ,_, IL-_NNP 10_CD
          expression_NN also_RB correlated_JJ with_IN expression_NN of_IN TRANCE_NNP ._.
          Although_IN it_PRP is_VBZ possible_JJ that_IN IL-_NNP 10_CD produced_VBN by_IN these_DT
          cells_NNS inhibited_VBD T-_NNP cell_NN activation_NN in_IN the_DT synovium_NN ,_, TRANCE_NNP
          expressed_VBN by_IN these_DT same_JJ cells_NNS might_MD function_VB to_TO activate_VBP
          dendritic_JJ cells_NNS and_CC indirectly_RB stimulate_VB T_NN cells_NNS ,_,
          mediating_VBG inflammation_NN in_IN the_DT synovium_NN ._. These_DT results_NNS
          imply_VBP that_IN individual_JJ T_NN cells_NNS in_IN the_DT synovium_NN might_MD have_VB
          different_JJ ,_, and_CC sometimes_RB opposite_JJ functional_JJ
          activities_NNS ._.
          LT-α_NNP expression_NN correlated_JJ with_IN CCR_NNP 6_CD expression_NN by_IN
          synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. It_PRP has_VBZ been_VBN reported_VBN that_IN
          CCR_NNP 6_CD is_VBZ expressed_VBN by_IN resting_VBG peripheral_JJ memory_NN T_NN cells_NNS [_NN
          17_CD ]_NN ,_, whereas_IN LT-α_NNP expression_NN is_VBZ associated_VBN with_IN the_DT
          presence_NN of_IN lymphocytic_JJ aggregates_NNS in_IN synovial_NN tissue_NN [_NN
          7_CD ]_NN ._. The_DT correlation_NN between_IN the_DT expression_NN of_IN these_DT two_CD
          markers_NNS therefore_RB suggests_VBZ the_DT possibility_NN that_IN CCR_NNP 6_CD may_MD
          play_VB a_DT role_NN in_IN the_DT development_NN of_IN aggregates_NNS of_IN CD_NNP 4_CD +_NN T_NN
          cells_NNS that_WDT are_VBP characteristically_RB found_VBN in_IN rheumatoid_NN
          synovium_NN ._.
          TRANCE_NNP is_VBZ known_VBN to_TO be_VB expressed_VBN by_IN activated_VBN T_NN cells_NNS ,_,
          and_CC can_MD stimulate_VB dendritic_JJ cells_NNS and_CC osteoclasts_NNS [_NN 18_CD ]_NN ._.
          Of_IN note_NN ,_, TRANCE-mediated_NNP activation_NN of_IN osteoclasts_NNS has_VBZ
          recently_RB been_VBN shown_VBN [_NN 19_CD ]_NN to_TO play_VB an_DT important_JJ role_NN in_IN
          the_DT damage_NN to_TO bone_NN that_WDT is_VBZ found_VBN in_IN experimental_JJ models_NNS
          of_IN inflammatory_JJ arthritis_NN ._. It_PRP is_VBZ therefore_RB of_IN interest_NN
          that_IN TRANCE_NNP was_VBD expressed_VBN by_IN 3_CD -_: 16_CD %_NN of_IN the_DT RA_NNP synovial_NN CD_NNP 4_CD
          +_NN memory_NN T_NN cells_NNS ._. Of_IN note_NN ,_, 67_CD %_NN of_IN TNF-α-positive_NNP cells_NNS
          expressed_VBD TRANCE_NNP ._. In_IN concert_NN ,_, TNF-α_NNP and_CC TRANCE_NNP expressed_VBN
          by_IN this_DT subset_NN of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS might_MD make_VB them_PRP
          particularly_RB important_JJ in_IN mediating_VBG the_DT bony_NN erosions_NNS
          that_WDT are_VBP characteristic_NN of_IN RA_NNP ._.
          Interestingly_RB ,_, there_EX was_VBD a_DT correlation_NN between_IN
          expression_NN of_IN IFN-γ_NNP and_CC IL-_NNP 10_CD in_IN RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD
          +_NN memory_NN T_NN cells_NNS ._. In_IN RA_NNP peripheral_JJ blood_NN ,_, CD_NNP 154_CD expression_NN
          correlated_JJ with_IN that_DT of_IN CXCR_NNP 3_CD by_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. It_PRP
          has_VBZ been_VBN claimed_VBN [_NN 15_CD ]_NN that_IN CXCR_NNP 3_CD is_VBZ preferentially_RB
          expressed_VBN by_IN 
          in_IN vitro_NN generated_VBD Th_NNP 1_CD cells_NNS ._.
          However_RB ,_, in_IN the_DT present_JJ study_NN CXCR_NNP 3_CD did_VBD not_RB correlate_VBP
          with_IN IFN-γ_NNP expression_NN ._. Although_IN IFN-γ_NNP and_CC TNF-α_NNP mRNAs_NNS
          were_VBD expressed_VBN 
          in_IN vivo_NN by_IN peripheral_JJ blood_NN CD_NNP 4_CD +_NN T_NN
          cells_NNS from_IN RA_NNP patients_NNS ,_, LT-α_NNP mRNA_NN was_VBD not_RB detected_VBN ,_,
          whereas_IN IFN-γ_NNP ,_, TNF-α_NNP ,_, and_CC LT-α_NNP were_VBD not_RB detected_VBN in_IN
          samples_NNS from_IN healthy_JJ donors_NNS ._. These_DT findings_NNS indicate_VBP that_IN
          RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP stimulated_VBN 
          in_IN vivo_NN ,_, although_IN they_PRP do_VBP not_RB
          express_VB LT-α_NNP mRNA_NN ._. The_DT present_JJ studies_NNS indicate_VBP that_IN the_DT
          frequencies_NNS of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS that_WDT expressed_VBD IFN-γ_NNP
          in_IN the_DT blood_NN and_CC in_IN the_DT synovium_NN are_VBP comparable_JJ ._. These_DT
          results_NNS imply_VBP that_WDT activated_VBN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS migrate_VB
          between_IN blood_NN and_CC synovium_NN ,_, although_IN the_DT direction_NN of_IN the_DT
          trafficking_NN is_VBZ unknown_JJ ._. The_DT presence_NN of_IN LT-α_NNP mRNA_NN in_IN
          synovium_NN ,_, but_CC not_RB in_IN blood_NN ,_, indicates_VBZ that_IN CD_NNP 4_CD +_NN memory_NN
          cells_NNS are_VBP further_RBR activated_VBN in_IN the_DT synovium_NN ,_, and_CC that_IN
          these_DT activated_VBN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP retained_VBN in_IN the_DT
          synovium_NN until_IN LT-α_NNP mRNA_NN decreases_NNS ._.
          In_IN conclusion_NN ,_, CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP biased_VBN toward_IN
          Th_NNP 1_CD cells_NNS in_IN RA_NNP synovium_NN and_CC peripheral_JJ blood_NN ._. In_IN the_DT
          synovium_NN ,_, IFN-γ_NNP and_CC LT-α_NNP were_VBD produced_VBN by_IN individual_JJ
          cells_NNS ,_, whereas_IN in_IN the_DT rheumatoid_NN blood_NN no_DT LT-α-producing_NNP
          cells_NNS were_VBD detected_VBN ._. Furthermore_RB ,_, there_EX were_VBD modest_JJ
          correlations_NNS between_IN individual_JJ cells_NNS that_WDT expressed_VBD
          particular_JJ cytokines_NNS ,_, such_JJ as_IN IL-_NNP 10_CD ,_, and_CC certain_JJ
          chemokine_NN receptor_NN mRNAs_NNS ._.
        
      
      
        Introduction_NNP
        In_IN RA_NNP large_JJ numbers_NNS of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS infiltrate_VB
        the_DT inflamed_JJ synovium_NN [_NN 1_CD ,_, 2_CD ,_, 3_CD ]_NN ._. The_DT accumulated_VBN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS in_IN the_DT RA_NNP synovium_NN appear_VBP to_TO be_VB activated_VBN ,_,
        because_IN they_PRP express_VBP cytokines_NNS and_CC activation_NN markers_NNS [_NN 4_CD ,_,
        5_CD ,_, 6_CD ,_, 7_CD ,_, 8_CD ]_NN ._. Expressed_NNP cytokines_NNS and_CC activation_NN markers_NNS
        should_MD play_VB important_JJ roles_NNS in_IN the_DT pathogenesis_NNS of_IN RA_NNP ._.
        However_RB ,_, the_DT frequency_NN of_IN cytokine_NN expression_NN by_IN RA_NNP
        synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS has_VBZ not_RB been_VBN analyzed_VBN accurately_RB ._.
        Recently_RB ,_, the_DT roles_NNS of_IN chemokine_NN and_CC chemokine_NN receptor_NN
        interactions_NNS in_IN T-_NNP cell_NN migration_NN have_VBP been_VBN intensively_RB
        examined_VBN ._. Interactions_NNP of_IN chemokine_NN and_CC chemokine_NN receptors_NNS
        might_MD therefore_RB be_VB important_JJ for_IN the_DT accumulation_NN of_IN the_DT T_NN
        cells_NNS in_IN the_DT RA_NNP synovium_NN ._. Accordingly_RB ,_, correlation_NN of_IN
        cytokine_NN and_CC chemokine_NN receptor_NN expression_NN might_MD be_VB
        important_JJ in_IN delineating_VBG the_DT function_NN and_CC potential_JJ means_NNS
        of_IN accumulation_NN of_IN individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS in_IN the_DT RA_NNP
        synovium_NN ._.
        In_IN order_NN to_TO analyze_VB cytokine_NN ,_, activation_NN marker_NN ,_, and_CC
        chemokine_NN receptor_NN expression_NN by_IN individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN
        cells_NNS ,_, we_PRP used_VBD a_DT single-cell_JJ RT-PCR_NNP technique_NN ._. The_DT method_NN
        made_VBD it_PRP possible_JJ to_TO analyze_VB cytokine_NN and_CC chemokine_NN receptor_NN
        expression_NN by_IN individual_JJ RA_NNP synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS
        without_IN 
        in_IN vitro_NN stimulation_NN ,_, and_CC to_TO
        correlate_VBP cytokine_NN and_CC chemokine_NN receptor_NN expression_NN ._.
        Using_VBG this_DT technique_NN ,_, we_PRP analyzed_VBD cytokine_NN (_( IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_,
        IL-_NNP 6_CD ,_, IL-_NNP 10_CD ,_, IL-_NNP 13_CD ,_, IFN-γ_NNP ,_, TNF-α_NNP ,_, and_CC LT-α_NNP )_) ,_, activation_NN
        marker_NN (_( CD_NNP 154_CD [_NN CD_NNP 40_CD ligand_NN ]_NN and_CC TRANCE_NNP -_: also_RB called_VBN
        receptor_NN activator_NN of_IN nuclear_JJ factor-κ_JJ B_NNP ligand_NN [_NN RANKL_NNP ]_NN or_CC
        osteoclast_NN differentiation_NN factor_NN [_NN ODF_NNP ]_NN )_) ,_, and_CC chemokine_NN
        receptor_NN expression_NN by_IN individual_JJ CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS
        isolated_VBN from_IN rheumatoid_NN synovium_NN and_CC blood_NN ._. The_DT results_NNS
        indicate_VBP that_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP biased_VBN toward_IN Th_NNP 1_CD
        cells_NNS in_IN RA_NNP synovium_NN ,_, although_IN individual_JJ cells_NNS produced_VBD
        IFN-γ_NNP or_CC LT-α_NNP ,_, but_CC not_RB both_DT ._. A_DT similar_JJ pattern_NN of_IN cytokine_NN
        production_NN was_VBD observed_VBN with_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS from_IN RA_NNP
        blood_NN ,_, with_IN the_DT exception_NN that_IN no_DT cells_NNS expressing_VBG LT-α_NNP
        were_VBD detected_VBN ._. There_EX were_VBD modest_JJ correlations_NNS between_IN
        individual_JJ cells_NNS that_WDT expressed_VBD particular_JJ cytokine_NN and_CC
        chemokine_NN receptor_NN mRNAs_NNS ._.
      
      
        Materials_NNS and_CC method_NN
        
          Specimens_NNP
          Synovial_NNP tissues_NNS were_VBD obtained_VBN at_IN surgery_NN from_IN three_CD
          RA_NNP patients_NNS ._. The_DT synovial_NN tissue_NN was_VBD minced_JJ and_CC incubated_JJ
          with_IN 0_CD ._. 3_CD mg_NN /_NN ml_NN collagenase_NN (_( Sigma_NNP ,_, St_NNP Louis_NNP ,_, MO_NNP ,_, USA_NNP )_) for_IN
          1_CD h_NN at_IN 37_CD °_NN C_NNP in_IN RPMI_NNP 1640_CD medium_NN (_( Life_NNP Technologies_NNPS ,_,
          Gaithersburg_NNP ,_, MD_NNP ,_, USA_NNP )_) ._. Partially_NNP digested_VBN pieces_NNS of_IN the_DT
          tissue_NN were_VBD pressed_VBN through_IN a_DT metal_NN screen_NN to_TO obtain_VB
          single-cell_JJ suspensions_NNS ._. Mononuclear_NNP cells_NNS were_VBD then_RB
          isolated_VBN by_IN ficoll-hypaque_JJ (_( Pharmacia_NNP Biotech_NNP ,_,
          Piscataway_NNP ,_, NJ_NNP ,_, USA_NNP )_) gradient_NN centrifugation_NN ._. RA_NNP was_VBD
          diagnosed_VBN according_VBG to_TO the_DT American_NNP College_NNP of_IN
          Rheumatology_NNP criteria_NNS [_NN 20_CD ]_NN ._.
          Also_RB ,_, peripheral_JJ blood_NN mononuclear_NN cells_NNS were_VBD
          separated_VBN by_IN ficoll-hypaque_JJ gradient_NN centrifugation_NN from_IN
          two_CD RA_NNP patients_NNS and_CC a_DT normal_JJ donor_NN ._.
        
        
          Single_NNP cell_NN sorting_VBG and_CC reverse_VB transcription_NN
          polymerase_NN chain_NN reaction_NN
          The_DT method_NN for_IN construction_NN of_IN cDNA_NN libraries_NNS from_IN
          single_JJ cells_NNS was_VBD similar_JJ to_TO previously_RB reported_VBD
          techniques_NNS [_NN 21_CD ,_, 22_CD ]_NN ._. RA_NNP synovial_NN tissue_NN T_NN cells_NNS were_VBD
          analyzed_VBN without_IN 
          in_IN vitro_NN culture_NN or_CC stimulation_NN by_IN
          staining_VBG synovium_NN mononuclear_NN cells_NNS with_IN FITC-conjugated_NNP
          anti-_NN CD_NNP 4_CD mono-clonal_JJ antibody_NN (_( Q_NNP 4120_CD ;_: Sigma_NNP )_) and_CC
          PE-conjugated_NNP anti-_NN CD_NNP 45_CD RO_NNP monoclonal_NN antibody_NN (_( UCHL-_NNP 1_LS )_) ,_,
          after_IN which_WDT individual_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS were_VBD sorted_VBN
          in_IN a_DT 96_CD -_: well_RB PCR_NNP plate_NN (_( Robbins_NNP Scientific_NNP ,_, Sunnyvale_NNP ,_,
          CA_NNP ,_, USA_NNP )_) using_VBG the_DT FACStar_NNP Plus_NNP (_( Becton_NNP Dickinson_NNP ,_, San_NNP
          Jose_NNP ,_, CA_NNP ,_, USA_NNP )_) ._. Peripheral_NNP CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN single_JJ cells_NNS were_VBD
          also_RB sorted_VBN into_IN wells_NNS of_IN 96_CD -_: well_RB PCR_NNP plates_NNS using_VBG the_DT
          FACStar_NNP Plusflow_NNP cytometer_NN ._.
          Each_DT well_RB contained_VBN 4_CD μl_NN lysis_NNS buffer_NN (_( 50_CD mmol_NN /_NN l_NN
          Tris-_NNP HCl_NNP [_NN pH_NN 8_CD ._. 3_LS ]_NN ,_, 75_CD mmol_NN /_NN l_NN KCl_NNP ,_, 3_CD mmol_NN /_NN l_NN MgCl_NNP 
          2_CD ,_, 1_CD mmol_NN /_NN l_NN DTT_NNP ,_, 10_CD μmol_NN /_NN l_NN dNTP_NN
          [_NN Sigma_NNP ]_NN ,_, 5_CD U_NNP /_NN ml_NN PRIME_NNP RNase_NNP Inhibitor_NNP [_NN 5_CD Prime_NNP ?_. ?_. 3_CD Prime_NNP
          Incorporated_NNP ,_, Boulder_NNP ,_, CO_NNP ,_, USA_NNP ]_NN ,_, 300_CD U_NNP /_NN ml_NN RNAguard_NNP
          [_NN Pharmacia_NNP Biotech_NNP ]_NN ,_, 200_CD ng_NN /_NN ml_NN oligo_NN [_NN dT_NN ]_NN 
          24_CD [_NN Integrated_NNP DNA_NNP Technologies_NNPS
          Incorporated_NNP ,_, Coralville_NNP ,_, IA_NNP ,_, USA_NNP ]_NN ,_, and_CC 0_CD ._. 5_CD %_NN NP-_NNP 40_CD )_) ._. The_DT
          samples_NNS were_VBD heated_VBN to_TO 65_CD °_NN C_NNP for_IN 1_CD min_NN ,_, cooled_VBN to_TO 20_CD °_NN C_NNP for_IN
          3_CD min_NN ,_, and_CC maintained_VBD on_IN ice_NN ._. Two_CD units_NNS of_IN AMV_NNP Reverse_VBP
          Transcriptase_NNP (_( Promega_NNP ,_, Madison_NNP ,_, WI_NNP ,_, USA_NNP )_) and_CC 50_CD U_NNP of_IN
          M-MLV_NNP Reverse_VBP Transcriptase_NNP (_( Life_NNP Technologies_NNPS )_) was_VBD
          added_VBN ,_, and_CC the_DT samples_NNS were_VBD incubated_JJ at_IN 37_CD °_NN C_NNP for_IN 15_CD min_NN
          before_IN heat_NN inactivation_NN at_IN 65_CD °_NN C_NNP for_IN 10_CD min_NN ._. For_IN
          polyadenylate_NN tailing_VBG at_IN the_DT 3_CD '_POS end_NN of_IN the_DT cDNA_NN ,_, 5_CD μl_NN
          tailing_VBG buffer_NN (_( 200_CD mmol_NN /_NN l_NN potassium_NN cacodylate_NN [_NN pH_NN 7_CD ._. 2_CD ]_NN ,_,
          4_CD mmol_NN /_NN l_NN CoCl_NNP 
          2_CD ,_, 0_CD ._. 4_CD mmol_NN /_NN l_NN DTT_NNP )_) ,_, 2_CD mmol_NN /_NN l_NN dATP_NN
          (_( Roche_NNP ,_, Indianapolis_NNP ,_, IN_IN ,_, USA_NNP )_) ,_, and_CC 10_CD U_NNP terminal_NN
          transferase_NN (_( Roche_NNP )_) were_VBD added_VBN ,_, and_CC incubated_JJ at_IN 37_CD °_NN C_NNP for_IN
          20_CD min_NN ,_, followed_VBN by_IN heat_NN inactivation_NN at_IN 65_CD °_NN C_NNP for_IN 10_CD min_NN ._.
          To_TO amplify_VB the_DT cDNA_NN non-specifically_JJ ,_, PCR_NNP was_VBD performed_VBN
          with_IN 100_CD μl_NN of_IN 10_CD mmol_NN /_NN l_NN Tris-_NNP HCl_NNP (_( pH_NN 9_CD ._. 0_CD )_) ,_, 50_CD mmol_NN /_NN l_NN
          KCl_NNP ,_, 2_CD ._. 5_CD mmol_NN /_NN l_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 01_CD %_NN Triton-_NNP X_NNP ,_, 1_CD mmol_NN /_NN l_NN dNTP_NN ,_, 10_CD
          U_NNP Taq_NNP DNA_NNP polymerase_NN (_( Promega_NNP )_) ,_, and_CC 2_CD μmol_NN /_NN l_NN X-_NNP (_( dT_NN )_) 
          24_CD primer_NN (_( ATG_NNP TCG_NNP TCC_NNP AGG_NNP CCG_NNP CTC_NNP TGG_NNP
          ACA_NNP AAA_NNP TAT_NNP GAA_NNP TTC-dT_NNP 
          24_CD ;_: Integrated_NNP DNA_NNP Technologies_NNPS
          Incorporated_NNP )_) ._. Twenty-five_CD cycles_NNS of_IN amplification_NN were_VBD
          performed_VBN with_IN 1_CD min_NN at_IN 94_CD °_NN C_NNP ,_, 2_CD min_NN at_IN 42_CD °_NN C_NNP ,_, and_CC 6_CD min_NN at_IN
          72_CD °_NN C_NNP ,_, plus_CC 10_CD s_VBZ extension_NN per_IN cycle_NN ._. Afterward_RB ,_, 5_CD U_NNP Taq_NNP
          DNA_NNP polymerase_NN was_VBD added_VBN ,_, followed_VBN by_IN an_DT additional_JJ 25_CD
          cycles_NNS of_IN PCR_NNP ._.
          For_IN gene-specific_JJ amplification_NN ,_, 1_CD μl_NN of_IN
          nonspecifically_RB amplified_VBN cDNA_NN was_VBD amplified_VBN by_IN PCR_NNP in_IN 25_CD
          μ_NN l_NN 10_CD mmol_NN /_NN l_NN Tris-_NNP HCl_NNP (_( pH_NN 9_CD ._. 0_CD )_) ,_, 50_CD mmol_NN /_NN l_NN KCl_NNP ,_, 1_CD ._. 5_CD
          mmol_NN /_NN l_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 01_CD %_NN Triton-_NNP X_NNP ,_, 200_CD μmol_NN /_NN l_NN dNTP_NN
          and_CC 0_CD ._. 625_CD U_NNP Taq_NNP DNA_NNP polymerase_NN ._. The_DT cycling_NN program_NN was_VBD :_:
          94_CD °_NN C_NNP for_IN 1_CD min_NN ,_, 60_CD °_NN C_NNP for_IN 1_CD min_NN (_( 58_CD °_NN C_NNP :_: IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, IFN-γ_NNP )_) ,_,
          and_CC 72_CD °_NN C_NNP for_IN 1_CD min_NN for_IN 35_CD cycles_NNS ,_, followed_VBN by_IN a_DT final_JJ
          extension_NN for_IN 7_CD min_NN ._. For_IN nested_JJ amplification_NN ,_, 1_CD μl_NN of_IN
          amplified_VBN PCR_NNP reaction_NN mixture_NN was_VBD added_VBN to_TO a_DT second_JJ PCR_NNP
          reaction_NN mixture_NN (_( 50_CD μl_NN of_IN 10_CD mmol_NN /_NN l_NN Tris-_NNP HCl_NNP [_NN pH_NN 9_CD ._. 0_CD ]_NN ,_,
          50_CD mmol_NN /_NN l_NN KCl_NNP ,_, 1_CD ._. 5_CD mmol_NN /_NN l_NN MgCl_NNP 
          2_CD ,_, 0_CD ._. 01_CD %_NN Triton-_NNP X_NNP ,_, 200_CD μmol_NN /_NN l_NN dNTP_NN ,_,
          and_CC 1_CD ._. 25_CD U_NNP Taq_NNP DNA_NNP polymerase_NN )_) ._. The_DT cycling_NN program_NN was_VBD :_:
          94_CD °_NN C_NNP for_IN 1_CD min_NN ,_, 60_CD °_NN C_NNP for_IN 1_CD min_NN ,_, and_CC 72_CD °_NN C_NNP for_IN 1_CD min_NN for_IN 35_CD
          cycles_NNS ,_, followed_VBN by_IN a_DT final_JJ extension_NN for_IN 7_CD min_NN ._. The_DT PCR_NNP
          products_NNS were_VBD then_RB separated_VBN by_IN electrophoresis_NNS through_IN
          2_CD ._. 0_CD %_NN agarose_NN ._. The_DT primers_NNS were_VBD designed_VBN to_TO be_VB within_IN 600_CD
          bp_NN of_IN the_DT 3_CD '_POS end_NN of_IN each_DT mRNA_NN ._. The_DT primers_NNS used_VBN were_VBD as_IN
          shown_VBN in_IN Table_NNP 3_CD ._.
          To_TO confirm_VB that_IN the_DT PCR_NNP products_NNS were_VBD amplified_VBN from_IN
          the_DT corresponding_JJ genes_NNS ,_, the_DT nucleotide_NN sequences_NNS of_IN the_DT
          PCR_NNP products_NNS were_VBD analyzed_VBN ._. More_JJR than_IN five_CD PCR_NNP products_NNS
          of_IN each_DT cytokine_NN from_IN a_DT total_NN of_IN two_CD or_CC three_CD donors_NNS were_VBD
          sequenced_JJ ._. All_DT the_DT sequences_NNS of_IN the_DT PCR_NNP products_NNS were_VBD
          identical_JJ to_TO the_DT previously_RB published_VBN sequences_NNS (_( data_NNS not_RB
          shown_VBN )_) ._.
          To_TO confirm_VB that_IN each_DT well_RB contained_VBN only_RB one_CD cell_NN
          after_IN sorting_VBG ,_, TCR_NNP Vβ_NNP mRNA_NN was_VBD analyzed_VBN by_IN single-cell_JJ
          RT-PCR_NNP using_VBG Vβ_NNP family-specific_JJ primers_NNS ._. In_IN the_DT wells_NNS
          analyzed_VBD ,_, only_RB one_CD TCR_NNP Vβ_NNP was_VBD detected_VBN (_( data_NNS not_RB
          shown_VBN )_) ._.
        
        
          Statistical_NNP analyses_NNS
          To_TO analyze_VB correlations_NNS between_IN cytokines_NNS and_CC
          chemokine_NN receptor_NN expressions_NNS ,_, and_CC to_TO compare_VB
          frequencies_NNS of_IN chemokine_NN receptor-expressing_JJ cells_NNS
          between_IN different_JJ T-_NNP cell_NN subsets_NNS ,_, Fisher_NNP 's_POS exact_JJ
          probability_NN test_NN was_VBD used_VBN ._.
        
      
      
        Results_NNS
        
          Cytokine_NNP and_CC activation_NN marker_NN expression_NN by_IN
          individual_JJ rheumatoid_NN synovial_NN tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN
          cells_NNS
          Cytokine_NNP and_CC activation_NN marker_NN expressions_NNS by_IN
          individual_JJ CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS from_IN RA_NNP synovial_NN tissues_NNS
          were_VBD analyzed_VBN by_IN employing_VBG a_DT single-cell_JJ RT-PCR_NNP method_NN ._.
          Expressions_NNP of_IN mRNAs_NNS were_VBD analyzed_VBN in_IN 152_CD individual_JJ
          synovial_NN tissue_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS sorted_VBN from_IN three_CD RA_NNP
          patients_NNS in_IN which_WDT TCR_NNP Cβ_NNP mRNA_NN was_VBD detected_VBN ._. Cytokine_NNP and_CC
          activation_NN marker_NN expressions_NNS by_IN 50_CD synovial_NN tissue_NN CD_NNP 4_CD
          +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS (_( RA_NNP 1_LS )_) are_VBP shown_VBN in_IN Fig_NNP ._. 1_LS ._.
          Frequencies_NNP of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS that_WDT expressed_VBD
          cytokine_NN and_CC activation_NN marker_NN mRNA_NN in_IN RA_NNP synovium_NN are_VBP
          shown_VBN in_IN Table_NNP 1_CD ._. IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, and_CC IL-_NNP 6_CD were_VBD not_RB expressed_VBN
          by_IN the_DT synovial_NN tissue_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS ,_, whereas_IN
          2_CD -_: 20_CD %_NN of_IN cells_NNS expressed_VBD the_DT other_JJ mRNAs_NNS ._.
        
        
          Correlation_NNP of_IN the_DT expression_NN of_IN cytokines_NNS by_IN
          rheumatoid_NN synovial_NN tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS
          Few_JJ correlations_NNS between_IN cytokine_NN and_CC activation_NN
          marker_NN mRNAs_NNS were_VBD observed_VBN ._. Notably_RB ,_, no_DT cells_NNS contained_VBD
          mRNAs_NNS for_IN both_DT IFN-γ_NNP and_CC LT-α_NNP ,_, cytokines_NNS that_WDT are_VBP thought_VBN
          to_TO define_VB the_DT Th_NNP 1_CD phenotype_NN [_NN 9_CD ]_NN ._. However_RB ,_, the_DT frequency_NN
          of_IN TRANCE-positive_NNP cells_NNS in_IN IL-_NNP 10_CD -_: positive_JJ cells_NNS was_VBD
          significantly_RB higher_JJR than_IN that_DT in_IN IL-_NNP 10_CD -_: negative_JJ cells_NNS
          (_( Table_NNP 2_LS )_) ._. Moreover_RB ,_, the_DT frequency_NN of_IN TRANCE-positive_NNP
          cells_NNS in_IN TNF-α-positive_NNP cells_NNS was_VBD also_RB significantly_RB
          higher_JJR than_IN that_DT in_IN TNF-α-negative_NNP cells_NNS ._.
        
        
          Correlation_NNP of_IN cytokine_NN and_CC chemokine_NN receptor_NN
          expression_NN by_IN RA_NNP synovial_NN tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN
          cells_NNS
          Varying_JJ percentages_NNS of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS expressed_VBD
          CC_NNP and_CC CXC_NNP chemokine_NN receptors_NNS as_IN shown_VBN in_IN Tables_NNP 4_CD and_CC 5_CD ._.
          Thus_RB ,_, for_IN example_NN ,_, 21_CD %_NN of_IN RA_NNP synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS
          expressed_VBD CCR_NNP 5_CD ,_, 39_CD %_NN CCRb_NNP ,_, and_CC 19_CD %_NN CCR_NNP 7_CD mRNAs_NNS ,_, whereas_IN 16_CD %_NN
          expressed_VBD CXCR_NNP 3_CD and_CC 76_CD %_NN expressed_VBD CXCR_NNP 4_CD mRNAs_NNS ._. The_DT
          frequency_NN of_IN CCR_NNP 5_CD -_: positive_JJ cells_NNS in_IN IFN-γ-positive_NNP cells_NNS
          was_VBD significantly_RB higher_JJR than_IN that_DT in_IN IFN-γ-negative_NNP
          cells_NNS (_( Table_NNP 4_LS )_) ,_, whereas_IN the_DT frequency_NN of_IN CCR_NNP 6_CD -_: positive_JJ
          cells_NNS in_IN LT-α-positive_NNP cells_NNS was_VBD significantly_RB higher_JJR
          than_IN that_DT in_IN LT-α-negative_NNP cells_NNS ,_, and_CC the_DT frequency_NN of_IN
          CCR_NNP 7_CD -_: positive_JJ cells_NNS in_IN IL-_NNP 10_CD -_: positive_JJ cells_NNS was_VBD
          significantly_RB higher_JJR than_IN that_DT in_IN IL-_NNP 10_CD -_: negative_JJ cells_NNS ._.
          Furthermore_RB ,_, the_DT frequency_NN of_IN CXCR_NNP 4_CD -_: positive_JJ cells_NNS in_IN
          TRANCE-positive_NNP cells_NNS was_VBD significantly_RB higher_JJR than_IN that_DT
          in_IN TRANCE-negative_NNP cells_NNS (_( Table_NNP 5_LS )_) ._.
        
        
          Cytokine_NNP and_CC activation_NN marker_NN expression_NN by_IN
          peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS from_IN RA_NNP patients_NNS and_CC
          a_DT normal_JJ donor_NN
          Expressions_NNP of_IN cytokine_NN and_CC activation_NN marker_NN mRNAs_NNS
          was_VBD also_RB analyzed_VBN in_IN 48_CD individual_JJ peripheral_JJ blood_NN CD_NNP 4_CD
          +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS sorted_VBN from_IN two_CD RA_NNP patients_NNS and_CC in_IN 33_CD
          individual_JJ peripheral_JJ blood_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN cells_NNS sorted_VBN
          from_IN a_DT normal_JJ donor_NN ._. Frequencies_NNP of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS
          that_WDT expressed_VBD cytokine_NN and_CC activation_NN marker_NN mRNA_NN are_VBP
          shown_VBN in_IN Table_NNP 6_CD ._. IL-_NNP 2_CD ,_, IL-_NNP 4_CD ,_, IL-_NNP 6_CD ,_, and_CC LT-α_NNP were_VBD not_RB
          expressed_VBN by_IN the_DT RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD +_NN CD_NNP 45_CD RO_NNP +_NN T_NN
          cells_NNS ,_, whereas_IN 4_CD -_: 17_CD %_NN of_IN cells_NNS expressed_VBD the_DT other_JJ
          markers_NNS ._. The_DT most_RBS striking_JJ difference_NN between_IN RA_NNP synovial_NN
          tissue_NN and_CC peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS was_VBD the_DT
          presence_NN of_IN LT-α_NNP expression_NN in_IN the_DT former_NN ,_, but_CC not_RB in_IN the_DT
          latter_NN ._. IFN-γ_NNP and_CC TNF-α_NNP were_VBD not_RB expressed_VBN by_IN normal_JJ
          peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ,_, although_IN they_PRP were_VBD
          expressed_VBN by_IN RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._.
          Variable_NNP frequencies_NNS of_IN RA_NNP peripheral_JJ CD_NNP 4_CD +_NN memory_NN T_NN
          cells_NNS expressed_VBD chemokine_NN receptor_NN mRNAs_NNS ._. Except_IN for_IN
          significantly_RB decreased_VBD expressions_NNS of_IN CCR_NNP 5_CD and_CC CXCR_NNP 4_CD ,_,
          there_EX were_VBD no_DT differences_NNS between_IN chemokine_NN receptor_NN
          expressions_NNS by_IN synovial_NN tissue_NN and_CC peripheral_JJ blood_NN CD_NNP 4_CD
          +_NN memory_NN T_NN cells_NNS ._. In_IN peripheral_JJ blood_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ,_,
          there_EX was_VBD a_DT significant_JJ correlation_NN between_IN IFN-γ_NNP and_CC
          IL-_NNP 10_CD expressions_NNS ,_, and_CC IFN-γ_NNP and_CC CCR_NNP 6_CD expressions_NNS (_( 
          P_NN <_NN 0_CD ._. 05_CD ;_: Table_NNP 7_CD )_) ._. In_IN addition_NN ,_,
          CD_NNP 154_CD and_CC CXCR_NNP 3_CD expressions_NNS correlated_JJ (_( 
          P_NN <_NN 0_CD ._. 005_CD )_) ._. No_DT other_JJ correlations_NNS
          were_VBD detected_VBN (_( data_NNS not_RB shown_VBN )_) ._.
        
      
      
        Discussion_NNP
        The_DT present_JJ study_NN employed_VBN single-cell_JJ PCR_NNP technology_NN to_TO
        analyze_VB cytokine_NN mRNA_NN expressions_NNS by_IN unstimulated_JJ RA_NNP
        synovial_NN tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS immediately_RB after_IN
        isolation_NN ,_, without_IN 
        in_IN vitro_NN manipulation_NN ._. The_DT results_NNS
        are_VBP consistent_JJ with_IN the_DT Th_NNP 1_CD nature_NN of_IN rheumatoid_NN
        inflammation_NN ._. These_DT data_NNS showed_VBD that_IN 6_CD -_: 22_CD %_NN of_IN RA_NNP synovial_NN
        CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS produced_VBD IFN-γ_NNP mRNA_NN ._. Previous_JJ studies_NNS [_NN
        4_CD ,_, 5_CD ,_, 6_CD ]_NN reported_VBD that_IN 1_CD -_: 10_CD %_NN of_IN RA_NNP synovial_NN T_NN cells_NNS
        expressed_VBD IFN-γ_NNP protein_NN by_IN immunohistologic_JJ analysis_NN ._.
        Although_IN there_EX is_VBZ some_DT variation_NN in_IN the_DT results_NNS obtained_VBN
        with_IN the_DT different_JJ methodologies_NNS ,_, both_DT results_NNS are_VBP
        consistent_JJ with_IN the_DT conclusion_NN that_IN there_EX is_VBZ a_DT Th_NNP 1_CD bias_NN in_IN
        RA_NNP [_NN 3_CD ,_, 23_CD ]_NN ._. It_PRP is_VBZ noteworthy_JJ that_IN no_DT individual_JJ synovial_NN
        CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS expressed_VBD both_DT IFN-γ_NNP and_CC LT-α_NNP mRNA_NN ,_,
        even_RB though_IN these_DT are_VBP the_DT prototypic_JJ Th_NNP 1_CD cytokines_NNS [_NN 9_CD ]_NN ._.
        These_DT results_NNS imply_VBP that_IN ,_, in_IN the_DT synovium_NN ,_, regulation_NN of_IN
        IFN-γ_NNP and_CC LT-α_NNP must_MD vary_VB in_IN individual_JJ cells_NNS ,_, even_RB though_IN
        both_DT Th_NNP 1_CD cytokine_NN mRNAs_NNS can_MD be_VB expressed_VBN ._.
        The_DT present_JJ data_NN showed_VBD that_IN CCR_NNP 5_CD expression_NN correlated_JJ
        with_IN IFN-γ_NNP but_CC not_RB with_IN LT-α_NNP expression_NN by_IN synovial_NN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS ._. It_PRP has_VBZ been_VBN reported_VBN that_IN CCR_NNP 5_CD expression_NN
        is_VBZ upregulated_JJ in_IN RA_NNP synovial_NN fluid_NN and_CC synovial_NN tissue_NN T_NN
        cells_NNS [_NN 10_CD ,_, 11_CD ,_, 12_CD ]_NN ,_, and_CC that_IN CCR_NNP 5_CD Δ_NN 32_CD deletion_NN may_MD have_VB
        an_DT influence_NN on_IN clinical_JJ manifestations_NNS of_IN RA_NNP [_NN 13_CD ]_NN ,_,
        suggesting_VBG that_IN CCR_NNP 5_CD might_MD play_VB an_DT important_JJ role_NN in_IN RA_NNP ._.
        Recently_RB ,_, it_PRP has_VBZ been_VBN claimed_VBN [_NN 14_CD ,_, 15_CD ]_NN that_IN CCR_NNP 5_CD was_VBD
        preferentially_RB expressed_VBN by_IN Th_NNP 1_CD cell_NN lines_NNS ._. In_IN the_DT present_JJ
        study_NN ,_, however_RB ,_, CCR_NNP 5_CD was_VBD not_RB expressed_VBN by_IN all_DT IFN-γ_NNP
        expressing_VBG cells_NNS ._. Moreover_RB ,_, CCR_NNP 5_CD expression_NN did_VBD not_RB
        correlate_VBP with_IN expression_NN of_IN LT-α_NNP by_IN RA_NNP synovial_NN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS ,_, although_IN it_PRP correlated_JJ with_IN IFN-γ_NNP ._.
        Therefore_RB ,_, it_PRP is_VBZ unclear_JJ whether_IN CCR_NNP 5_CD is_VBZ a_DT marker_NN of_IN Th_NNP 1_CD
        cells_NNS in_IN RA_NNP synovium_NN ._.
        Of_IN RA_NNP synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS 6_CD -_: 14_CD %_NN expressed_VBD IL-_NNP 10_CD ,_, and_CC
        the_DT expression_NN correlated_JJ with_IN CCR_NNP 7_CD expression_NN ._. It_PRP has_VBZ been_VBN
        reported_VBN that_IN approximately_RB 1_CD ._. 5_CD %_NN of_IN synovial_NN T_NN cells_NNS
        express_VBP IL-_NNP 10_CD by_IN immunohistochemistry_NN [_NN 5_CD ]_NN ,_, and_CC that_IN 4_CD %_NN of_IN
        synovial_NN CD_NNP 4_CD +_NN T_NN cells_NNS have_VBP the_DT potential_NN to_TO express_VB IL-_NNP 10_CD [_NN
        3_CD ]_NN ._. Recently_RB ,_, it_PRP was_VBD reported_VBN [_NN 16_CD ]_NN that_IN ,_, in_IN the_DT blood_NN ,_,
        CCR_NNP 7_CD +_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS express_VBP lymph-node_JJ homing_VBG
        receptors_NNS and_CC lack_NN immediate_JJ effector_NN function_NN ,_, but_CC
        efficiently_RB stimulate_VB dendritic_JJ cells_NNS ._. However_RB ,_, because_IN 19_CD %_NN
        of_IN RA_NNP tissue_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS expressed_VBD CCR_NNP 7_CD and_CC there_EX
        was_VBD a_DT correlation_NN between_IN IL-_NNP 10_CD production_NN and_CC CCR_NNP 7_CD
        expression_NN ,_, these_DT cells_NNS may_MD play_VB a_DT unique_JJ role_NN in_IN the_DT
        synovium_NN as_IN opposed_VBN to_TO in_IN the_DT blood_NN ._. By_IN producing_VBG IL-_NNP 10_CD ,_,
        they_PRP may_MD exert_VB an_DT immunoregulatory_NN function_NN ._. In_IN addition_NN ,_,
        it_PRP is_VBZ interesting_JJ to_TO note_VB that_IN IL-_NNP 10_CD expression_NN also_RB
        correlated_JJ with_IN expression_NN of_IN TRANCE_NNP ._. Although_IN it_PRP is_VBZ
        possible_JJ that_IN IL-_NNP 10_CD produced_VBN by_IN these_DT cells_NNS inhibited_VBD
        T-_NNP cell_NN activation_NN in_IN the_DT synovium_NN ,_, TRANCE_NNP expressed_VBN by_IN
        these_DT same_JJ cells_NNS might_MD function_VB to_TO activate_VBP dendritic_JJ cells_NNS
        and_CC indirectly_RB stimulate_VB T_NN cells_NNS ,_, mediating_VBG inflammation_NN in_IN
        the_DT synovium_NN ._. These_DT results_NNS imply_VBP that_IN individual_JJ T_NN cells_NNS
        in_IN the_DT synovium_NN might_MD have_VB different_JJ ,_, and_CC sometimes_RB
        opposite_JJ functional_JJ activities_NNS ._.
        LT-α_NNP was_VBD expressed_VBN by_IN 3_CD -_: 12_CD %_NN of_IN the_DT synovial_NN CD_NNP 4_CD +_NN memory_NN
        T_NN cells_NNS ,_, and_CC the_DT expression_NN correlated_JJ with_IN CCR_NNP 6_CD
        expression_NN ,_, which_WDT is_VBZ expressed_VBN by_IN 39_CD %_NN of_IN the_DT synovial_NN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS ._. However_RB ,_, there_EX were_VBD no_DT LT-α-expressing_NNP CD_NNP 4_CD
        +_NN T_NN cells_NNS that_WDT also_RB produced_VBN IFN-γ_NNP ,_, although_IN synovial_NN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS that_WDT produced_VBD each_DT cytokine_NN were_VBD found_VBN in_IN
        abundance_NN ._. It_PRP has_VBZ been_VBN reported_VBN that_IN CCR_NNP 6_CD is_VBZ expressed_VBN by_IN
        resting_VBG peripheral_JJ memory_NN T_NN cells_NNS [_NN 17_CD ]_NN ,_, whereas_IN LT-α_NNP
        expression_NN is_VBZ associated_VBN with_IN the_DT presence_NN of_IN lymphocytic_JJ
        aggregates_NNS in_IN synovial_NN tissue_NN [_NN 7_CD ]_NN ._. The_DT correlation_NN between_IN
        the_DT expression_NN of_IN these_DT two_CD markers_NNS therefore_RB suggests_VBZ the_DT
        possibility_NN that_IN CCR_NNP 6_CD might_MD play_VB a_DT role_NN in_IN the_DT development_NN
        of_IN aggregates_NNS of_IN CD_NNP 4_CD +_NN T_NN cells_NNS that_WDT are_VBP characteristically_RB
        found_VBN in_IN rheumatoid_NN synovium_NN ._.
        TRANCE_NNP is_VBZ known_VBN to_TO be_VB expressed_VBN by_IN activated_VBN T_NN cells_NNS ,_,
        and_CC can_MD stimulate_VB dendritic_JJ cells_NNS and_CC osteoclasts_NNS [_NN 18_CD ]_NN ._. Of_IN
        note_NN ,_, TRANCE-mediated_NNP activation_NN of_IN osteoclasts_NNS has_VBZ
        recently_RB been_VBN shown_VBN [_NN 19_CD ]_NN to_TO play_VB an_DT important_JJ role_NN in_IN the_DT
        damage_NN to_TO bone_NN found_VBD in_IN experimental_JJ models_NNS of_IN inflammatory_JJ
        arthritis_NN ._. Recently_RB ,_, the_DT presence_NN of_IN TRANCE_NNP in_IN rheumatoid_NN
        synovium_NN was_VBD reported_VBN [_NN 24_CD ,_, 25_CD ]_NN ._. It_PRP is_VBZ therefore_RB of_IN
        interest_NN that_IN TRANCE_NNP was_VBD expressed_VBN by_IN 3_CD -_: 16_CD %_NN of_IN the_DT RA_NNP
        synovial_NN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. Of_IN note_NN ,_, TRANCE_NNP expression_NN
        correlated_JJ with_IN IL-_NNP 10_CD ,_, TNF-α_NNP ,_, and_CC CXCR_NNP 4_CD expressions_NNS ._.
        Especially_RB noteworthy_JJ was_VBD that_IN 67_CD %_NN of_IN TNF-α-positive_NNP cells_NNS
        expressed_VBD TRANCE_NNP ._. In_IN concert_NN ,_, TNF-α_NNP and_CC TRANCE_NNP expressed_VBN by_IN
        this_DT subset_NN of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS might_MD make_VB them_PRP
        particularly_RB important_JJ in_IN mediating_VBG the_DT bony_NN erosions_NNS that_WDT
        are_VBP characteristic_NN of_IN RA_NNP ._.
        Interestingly_RB ,_, there_EX was_VBD a_DT correlation_NN between_IN
        expression_NN of_IN IFN-γ_NNP and_CC IL-_NNP 10_CD in_IN RA_NNP peripheral_JJ blood_NN CD_NNP 4_CD
        +_NN memory_NN T_NN cells_NNS ._. Production_NN of_IN IL-_NNP 10_CD in_IN humans_NNS differs_VBZ from_IN
        that_DT in_IN the_DT mouse_NN ,_, in_IN that_DT IL-_NNP 10_CD production_NN does_VBZ not_RB appear_VB
        to_TO be_VB restricted_VBN to_TO Th_NNP 2_CD cells_NNS [_NN 9_CD ]_NN ._. As_IN noted_VBD here_RB ,_, RA_NNP
        peripheral_JJ CD_NNP 4_CD +_NN T_NN cells_NNS could_MD express_VB both_DT IFN-γ_NNP and_CC IL-_NNP 10_CD ._.
        In_IN RA_NNP peripheral_JJ blood_NN ,_, CD_NNP 154_CD expression_NN correlated_JJ with_IN
        CXCR_NNP 3_CD by_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS ._. It_PRP has_VBZ been_VBN claimed_VBN [_NN 15_CD ]_NN
        that_IN CXCR_NNP 3_CD was_VBD preferentially_RB expressed_VBN by_IN 
        in_IN vitro_NN generated_VBD Th_NNP 1_CD cells_NNS ._.
        However_RB ,_, in_IN the_DT present_JJ study_NN CXCR_NNP 3_CD did_VBD not_RB correlate_VBP with_IN
        IFN-γ_NNP expression_NN ._. Although_IN IFN-γ_NNP and_CC TNF-α_NNP mRNAs_NNS were_VBD
        expressed_VBN 
        in_IN vivo_NN by_IN peripheral_JJ blood_NN CD_NNP 4_CD +_NN T_NN
        cells_NNS from_IN RA_NNP patients_NNS ,_, LT-α_NNP mRNA_NN was_VBD not_RB detected_VBN ,_, whereas_IN
        IFN-γ_NNP ,_, TNF-α_NNP ,_, and_CC LT-α_NNP were_VBD not_RB detected_VBN from_IN healthy_JJ
        donors_NNS ._. These_DT findings_NNS indicate_VBP that_IN RA_NNP peripheral_JJ blood_NN
        CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP stimulated_VBN 
        in_IN vivo_NN ,_, but_CC that_IN they_PRP do_VBP not_RB
        express_VB LT-α_NNP mRNA_NN ._. Previous_JJ studies_NNS have_VBP documented_VBN the_DT
        presence_NN of_IN IFN-γ_NNP and_CC IL-_NNP 10_CD mRNA_NN in_IN circulating_VBG T_NN cells_NNS of_IN
        RA_NNP patients_NNS [_NN 26_CD ,_, 27_CD ]_NN ._. The_DT present_JJ studies_NNS indicate_VBP that_IN
        the_DT frequency_NN of_IN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS that_WDT express_VBP IFN-γ_NNP in_IN
        the_DT blood_NN and_CC synovium_NN is_VBZ comparable_JJ ,_, although_IN the_DT
        percentages_NNS that_WDT secrete_NN IFN-γ_NNP are_VBP not_RB known_VBN ._. These_DT results_NNS
        imply_VBP that_WDT activated_VBN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS migrate_VB between_IN
        blood_NN and_CC synovium_NN ,_, although_IN the_DT direction_NN of_IN the_DT
        trafficking_NN is_VBZ unknown_JJ ._. The_DT presence_NN of_IN LT-α_NNP mRNA_NN in_IN
        synovium_NN but_CC not_RB in_IN blood_NN indicates_VBZ that_IN CD_NNP 4_CD +_NN memory_NN cells_NNS
        are_VBP further_RBR activated_VBN in_IN the_DT synovium_NN ,_, and_CC that_IN these_DT
        activated_VBN CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP retained_VBN in_IN the_DT synovium_NN
        until_IN LT-α_NNP mRNA_NN decreases_NNS ._.
        In_IN conclusion_NN ,_, CD_NNP 4_CD +_NN memory_NN T_NN cells_NNS are_VBP biased_VBN toward_IN Th_NNP 1_CD
        cells_NNS in_IN RA_NNP synovium_NN and_CC peripheral_JJ blood_NN ._. In_IN the_DT synovium_NN ,_,
        IFN-γ_NNP and_CC LT-α_NNP were_VBD produced_VBN by_IN individual_JJ cells_NNS ,_, whereas_IN
        in_IN the_DT rheumatoid_NN blood_NN no_DT LT-α-producing_NNP cells_NNS were_VBD
        detected_VBN ._. Furthermore_RB ,_, there_EX were_VBD modest_JJ correlations_NNS
        between_IN individual_JJ cells_NNS that_WDT expressed_VBD particular_JJ
        cytokines_NNS and_CC certain_JJ chemokine_NN receptor_NN mRNAs_NNS ._.
      
    
  
